Результаты поиска - William Kevin Kelly

Отмена результатов
  1. 1
    Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer

    Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer по Karen E. Knudsen, William Kevin Kelly

    Опубликовано 2011
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Clinical Trials in Relapsed Prostate Cancer: Defining the Target

    Clinical Trials in Relapsed Prostate Cancer: Defining the Target по Howard I. Scher, Madhu Mazumdar, William Kevin Kelly

    Опубликовано 1996
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  3. 3
    Relevance of pRB Loss in Human Malignancies

    Relevance of pRB Loss in Human Malignancies по Amy C. Mandigo, Scott A. Tomlins, William Kevin Kelly, Karen E. Knudsen

    Опубликовано 2021
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  4. 4
    Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria

    Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria по Tongzu Liu, Bethany N. Hannafon, Lance Gill, William Kevin Kelly, Doris M. Benbrook

    Опубликовано 2007
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    Prostate Cancer Clinical Trial End Points: “RECIST”ing a Step Backwards

    Prostate Cancer Clinical Trial End Points: “RECIST”ing a Step Backwards по Howard I. Scher, Michael J. Morris, William Kevin Kelly, Lawrence H. Schwartz, Glenn Heller

    Опубликовано 2005
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  6. 6
    Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer

    Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer по Kevin Zarrabi, Vivek Narayan, Patrick Mille, Matthew R. Zibelman, Benjamin Miron, Babar Bashir, William Kevin Kelly

    Опубликовано 2023
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  7. 7
    A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony‐stimulating factor support in patients with hormone‐refractory prostate carcinoma

    A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony‐stimulating factor support in patients with hormone‐refractory prostate carcinoma по William Oh, Susan Halabi, William Kevin Kelly, Cary Werner, Paul A. Godley, Nicholas J. Vogelzang, Eric J. Small

    Опубликовано 2003
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Cellular rewiring in lethal prostate cancer: the architect of drug resistance

    Cellular rewiring in lethal prostate cancer: the architect of drug resistance по Marc Cárceles-Cordon, William Kevin Kelly, Leonard G. Gomella, Karen E. Knudsen, Verónica Rodríguez-Bravo, Josep Domingo-Domènech

    Опубликовано 2020
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  9. 9
    Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer

    Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer по Diana Simão, Kevin Zarrabi, José Leão Mendes, Ricardo da Luz, Jorge A. García, William Kevin Kelly, Pedro C. Barata

    Опубликовано 2023
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  10. 10
    Radium-223 mechanism of action: implications for use in treatment combinations

    Radium-223 mechanism of action: implications for use in treatment combinations по Michael J. Morris, Eva Corey, Theresa A. Guise, James L. Gulley, William Kevin Kelly, David I. Quinn, Arne Scholz, George Sgouros

    Опубликовано 2019
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  11. 11
    A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate‐resistant prostate cancer

    A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate‐resistant prostate cancer по Joel Picus, Susan Halabi, William Kevin Kelly, Nicholas J. Vogelzang, Young E. Whang, Ellen B. Kaplan, Walter M. Stadler, Eric J. Small

    Опубликовано 2010
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    STEAP1–4 (Six-Transmembrane Epithelial Antigen of the Prostate 1–4) and Their Clinical Implications for Prostate Cancer

    STEAP1–4 (Six-Transmembrane Epithelial Antigen of the Prostate 1–4) and Their Clinical Implications for Prostate Cancer по Michael Xu, Latese Evans, Candice L. Bizzaro, Fabio Quaglia, Cecilia E. Verrillo, Li Li, Julia Stieglmaier, Matthew J. Schiewer, Lucia R. Languino, William Kevin Kelly

    Опубликовано 2022
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  13. 13
    Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer

    Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer по Michael J. Morris, Daisy Huang, William Kevin Kelly, Susan F. Slovin, Ryan D. Stephenson, C. Eicher, A. Delacruz, Tracy Curley, Lawrence H. Schwartz, Howard I. Scher

    Опубликовано 2009
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    A polyvalent vaccine for high-risk prostate patients: “are more antigens better?”

    A polyvalent vaccine for high-risk prostate patients: “are more antigens better?” по Susan F. Slovin, Govind Ragupathi, Celina Fernandez, Meghan Diani, Matthew P. Jefferson, Andrew S. Wilton, William Kevin Kelly, Michael J. Morris, David B. Solit, Henrik Clausen, Philip O. Livingston, Howard I. Scher

    Опубликовано 2007
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    Fluorodeoxyglucose Positron Emission Tomography as an Outcome Measure for Castrate Metastatic Prostate Cancer Treated with Antimicrotubule Chemotherapy

    Fluorodeoxyglucose Positron Emission Tomography as an Outcome Measure for Castrate Metastatic Prostate Cancer Treated with Antimicrotubule Chemotherapy по Michael J. Morris, Timothy Akhurst, Steven M. Larson, Marisa Ditullio, Elaina Chu, Karen L. Siedlecki, David Verbel, Glenn Heller, William Kevin Kelly, Susan F. Slovin, Lawrence B. Schwartz, Howard I. Scher

    Опубликовано 2005
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities

    Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities по Grace L. Lu‐Yao, Nikita Nikita, Scott W. Keith, Ginah Nightingale, Krupa Gandhi, Sarah Hegarty, Timothy R. Rebbeck, Andrew E. Chapman, Philip W. Kantoff, Jennifer Cullen, Leonard G. Gomella, William Kevin Kelly

    Опубликовано 2019
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    Small extracellular vesicles modulated by αVβ3 integrin induce neuroendocrine differentiation in recipient cancer cells

    Small extracellular vesicles modulated by αVβ3 integrin induce neuroendocrine differentiation in recipient cancer cells по Fabio Quaglia, Shiv Ram Krishn, George G. Daaboul, Srawasti Sarker, Raffaella Pippa, Josep Domingo-Doménech, Gaurav Kumar, Paolo Fortina, Peter A. McCue, William Kevin Kelly, Himisha Beltran, Qin Liu, Lucia R. Languino

    Опубликовано 2020
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    Novel Actions of Next-Generation Taxanes Benefit Advanced Stages of Prostate Cancer

    Novel Actions of Next-Generation Taxanes Benefit Advanced Stages of Prostate Cancer по Renée de Leeuw, Lisa D. Berman-Booty, Matthew J. Schiewer, Stephen J. Ciment, Robert B. Den, Adam P. Dicker, William Kevin Kelly, Edouard J. Trabulsi, Costas D. Lallas, Leonard G. Gomella, Karen E. Knudsen

    Опубликовано 2015
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

    Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Can... по William Kevin Kelly, Susan Halabi, Michael A. Carducci, Daniel J. George, John F. Mahoney, Walter M. Stadler, Michael J. Morris, Philip W. Kantoff, J. Paul Monk, Ellen B. Kaplan, Nicholas J. Vogelzang, Eric J. Small

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    High‐dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma

    High‐dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma по Michael J. Morris, Òren Smaletz, David B. Solit, William Kevin Kelly, Susan F. Slovin, Carlos D. Flombaum, Tracy Curley, A. Delacruz, Lawrence Schwartz, Martin Fleisher, Andrew X. Zhu, Meghan Diani, Mary Anne Fallon, Howard I. Scher

    Опубликовано 2004
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: